Delivery Order SPE2DB24D9224-SPE2DB25FJGER

Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,339.18, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the provision of XTANDI 80 MG TABLET 60S, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award, valued at $8,622.72, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 firm fixed-price delivery order is for the supply of XTANDI 80 MG TABLET 60S, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...
This federal contract award, valued at $8,339.18, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that allows DLA to issue firm fixed-price orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military...
This federal contract award, valued at $12,508.77, was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the pharmaceutical product XTANDI 80 MG TABLET 60S, with a completion date of January 13, 2025. DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $8,339.18 delivery order is for the supply of XTANDI 80 MG TABLET 60S, a pharmaceutical product, and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 delivery order is for the supply of XTANDI 40 MG TABLET 120S, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
This federal contract award, valued at $16,678.36, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of XTANDI 40 MG TABLET 120S, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 firm fixed-price delivery order is for the supply of XTANDI 80 MG TABLET 60S, a specialized pharmaceutical product, to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 firm fixed-price delivery order is for the supply of XTANDI 80 mg tablets, a specialty oncology medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows...
  • SPE2DB24D9224
    Indefinite Delivery Contract
  • SPE2DB24D9224-SPE2DB25FJGER
    Delivery Order

This federal contract award, valued at $8,339.18, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of XTANDI 80 MG TABLET 60S, a specialized pharmaceutical product.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 5/8/25, 9:50 AM